|Articles|January 4, 2017
FDA's Criminal Investigation Head to Leave as Trump Takes Office
January 04, 2017
Advertisement
Reuters reports that George Karavetsos, director of the Food and Drug Administration's Office of Criminal Investigations (OCI), is to leave the agency. Karavetsos has been OCI director since January 2015. The report adds that Karavestos's "last day will be Jan. 20, the day Donald Trump is sworn in as president".
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
4
FDA Approves Lerochol for Adults with Elevated LDL Cholesterol
5
